Skip to search formSkip to main contentSkip to account menu

ME 3221

Known as: ME-3221, ME3221 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Biphenyl CompoundsTetrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
ME3221: A Novel Angiotensin II Receptor Antagonist
1998
1998
Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors.
1996
1996
PROTECTIVE EFFECTS OF ME3221 ON HYPERTENSIVE COMPLICATIONS AND LIFESPAN IN SALT‐LOADED STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS
1. A comparison was made on the protective effects of the following: ME3221, a competitive angiotensin AT1 receptor antagonist… 
1996
1996
ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats.
The protective effects of ME3221, 3-methoxy-2,6-dimethyl-4-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-y l]methoxy] pyridine, on aged… 
1996
1996
ME-3221 : ANTIHYPERTENSIVE ANGIOTENSIN II ANTAGONNIST
1995
1995
Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
1995
1995
EFFECT OF CHRONIC TREATMENT WITH ME3221 ON BLOOD PRESSURE AND MORTALITY IN AGED STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS
1. The protective effect of ME3221, a surmountable AT1 antagonist, on the hypertension and its concomitant complications in aged… 
1995
1995
Effects of Chronic Treatment with ME3221 on Blood Pressure and Hypertensive Complications in Aged Stroke-Prone Spontaneously Hypertensive Rats
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)